Catalyst

Slingshot members are tracking this event:

Allergan (AGN) Adds to Dermatology Programs in Agreement to Acquire Vitae Pharmaceuticals (VTAE) for ~$639 Million

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AGN

100%
VTAE

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Definitive Agreement, Vtp-43742, Vtp-38543, Contour Drug Discovery Platform, Dermatology Product Pipeline